Dizal: Announcement on the completion of the plan to increase the shareholding of the company's directors and senior management and the results of increasing their holdings
Dizhe Pharmaceutical: Announcement on the progress of implementation of the plan to increase the shareholding of the company\'s directors and senior management
Dizhe Pharmaceutical: The 2022 Restricted Stock Incentive Plan grants some Class I incentive recipients the first vesting period results and share listing announcement
Dizhe Pharmaceutical: Announcement on the company\'s plan to increase shareholding by directors and senior management and the company\'s “improve quality, increase efficiency and value return” action plan
Dizhe Pharmaceutical: An indicative announcement on changes in equity to less than 5% due to passive dilution of shareholders holding 5% or more of the shares and disclosure of simplified equity change reports
Dighe (Jiangsu) Pharmaceutical Co., Ltd. Simplified Equity Change Report
Dizhe Pharmaceutical: Announcement on shareholders\' partial share pledges
Digel Pharmaceuticals: Announcement on the fulfillment of the first vesting conditions for the first category of incentive recipients in the first grant period of the 2022 Restricted Stock Incentive Plan
Digel Pharmaceuticals: Supervisory Committee\'s verification opinion on the first category of incentive recipients granted for the first time in the 2022 restricted stock incentive plan, and the first vesting period of the first vesting period
Dizhe Pharmaceuticals: Legal opinion from Beijing Zhonglun Law Firm on the first grant of some matters in the first vesting period of the first vesting period of the 2022 restricted stock incentive plan of Dizhe (Jiangsu) Pharmaceutical Co., Ltd. that met
Digger Pharmaceuticals: Announcement on Granting Reserved Restricted Stock to Incentive Targets of the 2022 Restricted Stock Incentive Plan
Dizhe Pharmaceuticals: Legal Opinion of Beijing Zhonglun Law Firm on matters relating to the reservation grant of the 2022 Restricted Stock Incentive Plan of Dizhe (Jiangsu) Pharmaceutical Co., Ltd.
Digel Pharmaceuticals: Supervisory Committee\'s verification opinion on the list of incentive recipients reserved for the company\'s 2022 restricted stock incentive plan
Digel Pharmaceuticals: IPO Strategy Placement and Restricted Stock Listing and Circulation Notice
Digitzer (Jiangsu) Pharmaceutical Co., Ltd. issued stock prospectus to specific targets (declaration draft)
Letter of sponsorship from Huatai United Securities Co., Ltd. relating to the issuance of shares by Digitzer (Jiangsu) Pharmaceutical Co., Ltd. to specific targets
A listing letter from Huatai United Securities Co., Ltd. relating to the issuance of shares by Digitzer (Jiangsu) Pharmaceutical Co., Ltd. to specific targets
Beijing Zhonglun Law Firm\'s Supplementary Legal Opinion on the Issuance of Shares by Digel (Jiangsu) Pharmaceutical Co., Ltd. to Specific Targets (1)
Digger Pharmaceuticals: Prompt Notice on Issuing Stock Prospectus and Other Relevant Documents to Specific Targets to Update Financial Data
Digger Pharmaceuticals: Prompt Notice Concerning Changes in Shareholders\' Equity of 5% or More Than 1%
No Data
No Data